ANAHEIM, Calif., July 23 At the 2009 American Association of Physicists in Medicine (AAPM) annual meeting, July 26-30 in Anaheim, California, Elekta will demonstrate how the company's comprehensive VMAT solution can help health care providers deliver superior cancer care with precision and ease.
Offering a sophisticated set of tools to plan and deliver radiation treatments, Elekta booth 423 will highlight treatment planning software that eclipses other planning systems, an oncology-specific EMR that fosters seamless communication within the clinic, and a fully integrated treatment system that redefines precision, speed and control.
Discover the new paradigm in VMAT planning
An advanced, clinically relevant IMRT planning system, Monaco(R) brings innovative concepts to the clinic that help make the planning process easier, more straightforward and clinically reliable.
New VMAT tools enable users to create arc-based treatment plans using all of the features already available in Monaco. With reduced planning time and increased clinical throughput, Monaco with VMAT optimizes single or multiple non-coplanar arcs simultaneously, providing the flexibility and control needed for complex treatment plans.
"The receipt of 510(k) clearance from the FDA for Monaco with VMAT is a significant event on the way to final release of the planning software," said Joseph K. Jachinowski, President and CEO of Elekta North America. "The VMAT capabilities within Monaco will help clinicians choose the best treatment options available and improve quality of care."
Optimize treatment with the market-leading oncology EMR
Built upon 15 years of development, application and innovation, MOSAIQ(R) 2.0 increases productivity, elevates efficiency and facilitates high-quality patient care. Complete with new connectivity, new functions and database enhancements, while preserving the user interface MOSAIQ supports the entire cancer team by uniting diverse systems and devices.
"Simple and intuitive, yet incredibly powerful, MOSAIQ 2.0 is the next major milestone in the development of oncology information systems," said Jay Hoey, Executive Vice President of Product Creation for Elekta and CEO of Elekta Impac Software. "We've invested thousands of man-months of R&D and seriously advanced technology to deliver the most elegant, most comprehensive, most stable, and highest performing information product available for radiation and medical oncology."
Distinguish yourself with the definitive VMAT delivery system
Elekta Infinity integrates the most advanced capabilities available with unmatched ease of use. The only fully integrated treatment system that allows personalization of imaging and treatment workflows, Infinity can dramatically reduce IMRT treatment sessions with the flexibility of multiple arcs to improve conformance.
"Elekta has always focused on providing highly refined tools, like Infinity, that support specific clinical objectives, yet share a common foundation in terms of imaging, planning and information management," continues Jachinowski. "The result is a comprehensive treatment solution that frees clinicians to focus on patients, instead of the technology."
Elekta also plans to host several education seminars and events in conjunction with the annual meeting. For additional information and registration, visit elekta.com/aapmevents.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, visit elekta.com.